|
|
|
09161
|
|
|
P.I.:
|
George Somlo, MD
|
|
|
Title:
|
Role of Stat3 in Human Breast Cancer as a Target of Cancer Therapy
|
|
|
09147
|
|
|
P.I.:
|
George Somlo, MD
|
|
|
Title:
|
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoaduvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
|
|
|
09125
|
|
|
P.I.:
|
George Somlo, MD
|
|
|
Title:
|
A Randomized, Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzumab-MCC-DM1 VS. Capecitabine + Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab-Based Therapy
|
| | |
|
|
09091
|
|
|
P.I.:
|
George Somlo, MD
|
|
|
Title:
|
An Open Label, Single Arm, Phase 2 Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carilzomib Treatment Protocols
|
| | |
|
|
09079
|
|
|
P.I.:
|
George Somlo, MD
|
|
|
Title:
|
A Phase Ib Multiple Ascending Dose Study of BMS-833923 (XL 139) Alone or in Combination with Lenalidomide (Revlimid) Plus Dexamethasone or in Combination with Bortezomib (Velcade) in Subjects with Relapsed or Refractory Multiple Myeloma, BMS CA 194003
|
| | |
|